Frontiers in Oncology | Thoracic Oncology

Systematic Review

Published on 03 Nov 2022

Efficacy and safety of brigatinib in ALK-positive non-small cell lung cancer treatment: A systematic review and meta-analysis

in Thoracic Oncology

Puyuan Xing
Xuezhi Hao
Xin Zhang
Junling Li

Frontiers in Oncology

doi 10.3389/fonc.2022.920709

5,174 views
7 citations

Case Report

Published on 02 Nov 2022

Lung adenocarcinoma concurrent with congenital pulmonary aplasia of the right upper lobe: A case report

in Thoracic Oncology

Bo Min
Chu-xu Wang
Juan Liu
Li Gong
Cheng-xiang Wang
Xiao-hua Zuo

Frontiers in Oncology

doi 10.3389/fonc.2022.959502

1,534 views

Original Research

Published on 02 Nov 2022

Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma

in Thoracic Oncology

Jingyang Li
Qinyun Du
Jiayi Sun
Li Xiang
Shaohui Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.988332

2,515 views
5 citations

Case Report

Published on 01 Nov 2022

Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure

in Thoracic Oncology

Liyong Shi
Lianshun Lin
Yin Ding
Yiming Zeng
Xiaoyang Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1020875

4,502 views
23 citations

Original Research

Published on 01 Nov 2022

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma

in Thoracic Oncology

Jie Zhao
Guangjian Li
Guangqiang Zhao
Wei Wang
Zhenghai Shen
Yantao Yang
Yunchao Huang
Lianhua Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.986367

3,201 views
10 citations

Original Research

Published on 01 Nov 2022

A prognostic signature model for unveiling tumor progression in lung adenocarcinoma

in Thoracic Oncology

Zijian Li
Tao Zeng
Chong Zhou
Yan Chen
Wu Yin

Frontiers in Oncology

doi 10.3389/fonc.2022.1019442

3,359 views
5 citations

Brief Research Report

Published on 31 Oct 2022

Thymic cyst: Is attenuation artifactually increased on contrast-enhanced CT?

in Thoracic Oncology

Chao Wang
Jin Mao
Siyu Yang
Huanhuan Xie
Shan Wang
Ling Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.984770

1,411 views
1 citation

Original Research

Published on 31 Oct 2022

Single ultrasound-guided thoracic paravertebral block with a large volume of anesthetic for microwave ablation of lung tumors

in Thoracic Oncology

Yong Ni
Yulong Zhong
Yue Zhang
Yifei Tao
Jiang Pan
Yiming Zhao
Zhicheng Zhang
Yong Jin

Frontiers in Oncology

doi 10.3389/fonc.2022.955778

2,008 views
3 citations

Mini Review

Published on 28 Oct 2022

The sternum reconstruction: Present and future perspectives

in Thoracic Oncology

Beatrice Aramini
Valentina Masciale
Lorenzo Federico Zini Radaelli
Rossella Sgarzani
Massimo Dominici
Franco Stella

Frontiers in Oncology

doi 10.3389/fonc.2022.975603

8,872 views
6 citations

Original Research

Published on 28 Oct 2022

Automated 3D segmentation of the aorta and pulmonary artery for predicting outcomes after thoracoscopic lobectomy in lung cancer patients

in Thoracic Oncology

Hsin-Ying Lee
Yu-Jung Chung
Hao-Jen Wang
Xu-Heng Chiang
Li-Wei Chen
Yan-Ting Lin
Yi-Chieh Lee
Hsao-Hsun Hsu
Yeun-Chung Chang
Chung-Ming Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1027036

2,409 views

Case Report

Published on 27 Oct 2022

Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma

in Thoracic Oncology

Linus D. Kloker
Branko Calukovic
Katrin Benzler
Alexander Golf
Sebastian Böhm
Sven Günther
Marius Horger
Simone Haas
Susanne Berchtold
Julia Beil

Frontiers in Oncology

doi 10.3389/fonc.2022.995744

3,974 views
10 citations

Original Research

Published on 27 Oct 2022

DNA methylation topology differentiates between normal and malignant in cell models, resected human tissues, and exfoliated sputum cells of lung epithelium

in Thoracic Oncology

Jian Tajbakhsh
Fariborz Mortazavi
Nirdesh K. Gupta

Frontiers in Oncology

doi 10.3389/fonc.2022.991120

1,694 views
4 citations

Case Report

Published on 27 Oct 2022

Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review

in Thoracic Oncology

Jiangfang Tian
Zhen Lin
Yueyun Chen
Yang Fu
Zhenyu Ding

Frontiers in Oncology

doi 10.3389/fonc.2022.1006634

3,013 views
9 citations

Case Report

Published on 27 Oct 2022

Significant response of pulmonary sarcomatoid carcinoma with obstructive atelectasis to treatment with the PD-1 inhibitor camrelizumab combined with transbronchial cryoablation: A case report and literature review

in Thoracic Oncology

Jiayun Nian
Yong Zhu
Qi Fu
Guowang Yang
Xiaomin Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1013047

2,731 views
7 citations

Review

Published on 27 Oct 2022

MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis

in Thoracic Oncology

Linrui Xu
Faping Wang
Fengming Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.1013299

8,483 views
13 citations

Review

Published on 27 Oct 2022

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer

in Thoracic Oncology

Xiaoxu Fang
Shaokun Yu
Yingying Jiang
Yan Xiang
Kaihua Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.1027664

5,946 views
12 citations